Quality-Adjusted Life Years (QALYs) in Ageing Research

What a QALY Measures

A quality-adjusted life year combines survival time with a health-related quality weight, so one year in full health counts as 1.0 QALY and years in poorer health count as fractions of a QALY. This allows analyses to compare interventions that affect both mortality and morbidity using a single outcome metric. [1] [3]

How QALYs Are Estimated in Ageing Studies

In ageing research, QALY estimates usually combine life-table or trial-based survival with utility scores from generic instruments such as EQ-5D. The EuroQol framework was developed to standardize this kind of health-state description, and it remains widely used in economic evaluations that include older populations. [2] [4] [5]

Why QALYs Matter for Healthspan Research

Healthspan-focused work is often concerned with delaying disability, preserving function, and reducing time lived with disease burden. Because QALYs integrate quality and quantity of life, they are commonly used to compare whether different prevention or care strategies generate better value across these goals. [1] [3] [4]

Methodological Limits in Older Populations

Reviews focused on older adults report that commonly used utility instruments can underrepresent domains that are highly relevant in late life, including autonomy, social participation, and broader wellbeing. For this reason, several analyses in aged-care settings discuss pairing generic measures with tools such as ICECAP-O or ASCOT when intervention effects extend beyond narrow health status. [5] [6]

Interpretation and Equity Debates

QALY-based comparisons also raise normative questions in ageing policy, especially when interventions for groups with shorter remaining life expectancy appear less cost-effective under conventional assumptions. Methodological work on distributional cost-effectiveness analysis was developed partly to make equity trade-offs explicit rather than leaving them implicit in a single average-effect estimate. [3] [7] [8]

Summary

In ageing research, QALYs are a practical cross-disease metric for linking survival and quality of life, but their interpretation depends on measurement choices and ethical assumptions. For healthspan analysis, they are most informative when paired with transparent discussion of what is captured and what is not. [1] [5] [8]

References

1. Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: the basics. Value in Health. https://pubmed.ncbi.nlm.nih.gov/19250132/
2. EuroQol Group. (1990). EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. https://pubmed.ncbi.nlm.nih.gov/10109801/
3. Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: the QALY and utilities. British Medical Bulletin. https://pubmed.ncbi.nlm.nih.gov/21037243/
4. Dawoud, D., et al. (2022). Capturing what matters: updating NICE methods guidance on measuring and valuing health. Quality of Life Research. https://pubmed.ncbi.nlm.nih.gov/35247152/
5. Bulamu, N. B., Kaambwa, B., & Ratcliffe, J. (2015). A systematic review of instruments for measuring outcomes in economic evaluation within aged care. Health and Quality of Life Outcomes. https://pubmed.ncbi.nlm.nih.gov/26553129/
6. Makai, P., et al. (2014). Quality of life instruments for economic evaluations in health and social care for older people: a systematic review. Social Science & Medicine. https://pubmed.ncbi.nlm.nih.gov/24565145/
7. Huter, K., et al. (2016). Economic evaluation of health promotion for older people: methodological problems and challenges. BMC Health Services Research. https://pmc.ncbi.nlm.nih.gov/articles/PMC5016726/
8. Asaria, M., Griffin, S., & Cookson, R. (2016). Distributional cost-effectiveness analysis: a tutorial. Medical Decision Making. https://pmc.ncbi.nlm.nih.gov/articles/PMC4853814/